One week after engrafting glioma cells to the brain of mice, the LPS/IFN‐γ MVs were infused in the tumor region, and one week after, a significant reduction of tumor size was observed, compared to the infusion of IL‐4 MVs that resulted in the increased tumor size. This evidence concerns the gene IL4 and central nervous system cancer.